HEPION PHARMACEUTICALS, INC. Number of Reporting Units
HEPION PHARMACEUTICALS, INC. (HEPA) reported Number of Reporting Units of 1 segment for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2019-11-14
- HEPION PHARMACEUTICALS, INC. number of reporting units for the quarter ending 2018-03-31 was 1.00 segment.
- HEPION PHARMACEUTICALS, INC. number of reporting units for the quarter ending 2017-09-30 was 1.00 segment.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month |
|---|---|---|---|
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-08-14 | ||
| 2018-09-30 | 1.00 segment 10-Q · filed 2019-05-15 | ||
| 2018-06-30 | 1.00 segment 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | 1.00 segment 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | 1.00 segment 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |